Novo Integrated Sciences Cash Flow from Investing Activities 2012-2024 | NVOS
Novo Integrated Sciences cash flow from investing activities from 2012 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Novo Integrated Sciences Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-0 |
| 2023 | $-0 |
| 2022 | $0 |
| 2021 | $3 |
| 2020 | $1 |
| 2019 | $-1 |
| 2018 | $-0 |
| 2017 | $-1 |
| 2016 | $0 |
| 2016 | $-0 |
| 2015 | $0 |
| 2014 | $-0 |
| 2013 | $0 |
| 2012 | $-0 |
| 2012 | $-0 |
| 2011 | $-0 |
| 2011 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $18.777B | 18.97 |
| DaVita (DVA) | United States | $12.238B | 15.61 |
| Encompass Health (EHC) | United States | $10.200B | 22.86 |
| Chemed (CHE) | United States | $9.006B | 28.86 |
| Option Care Health (OPCH) | United States | $5.740B | 27.52 |
| Elanco Animal Health (ELAN) | United States | $5.213B | 11.54 |
| RadNet (RDNT) | United States | $3.681B | 78.92 |
| Amedisys (AMED) | United States | $3.039B | 21.49 |
| LifeStance Health (LFST) | United States | $2.561B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.797B | 20.82 |
| Astrana Health (ASTH) | United States | $1.554B | 34.84 |
| U.S Physical Therapy (USPH) | United States | $1.099B | 28.05 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.057B | 0.00 |
| Pennant (PNTG) | United States | $0.866B | 34.93 |
| Atai Life Sciences (ATAI) | Germany | $0.270B | 0.00 |
| Bioqual (BIOQ) | United States | $0.051B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |